Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors

[Image: see text] Antibacterials with a novel mechanism of action offer a great opportunity to combat widespread antimicrobial resistance. Bacterial DNA Gyrase is a clinically validated target. Through physiochemical property optimization of a pyrazolopyridone hit, a novel class of GyrB inhibitors w...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ACS Med Chem Lett
Auteurs principaux: Zhang, Jing, Yang, Qingyi, Romero, Jan Antoinette C., Cross, Jason, Wang, Bin, Poutsiaka, Katherine M., Epie, Felix, Bevan, Douglas, Wu, Yuchuan, Moy, Terence, Daniel, Anu, Chamberlain, Brian, Carter, Nicole, Shotwell, Joseph, Arya, Anu, Kumar, Vipul, Silverman, Jared, Nguyen, Kien, Metcalf, Chester A., Ryan, Dominic, Lippa, Blaise, Dolle, Roland E.
Format: Artigo
Langue:Inglês
Publié: American Chemical Society 2015
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4601062/
https://ncbi.nlm.nih.gov/pubmed/26487916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.5b00266
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires